Klin Onkol 2009; 22(3): 94-97.
Summary
The construction and launch of the cyclotron & PET centre at the Masaryk Memorial Cancer Institute, which is run in cooperation with the Nuclear Research Institute Praha‑Řež, allows the Masaryk memorial Cancer Institute to engage in the research, development and application of new radiopharmace uticals including compounds labelled by short‑living positron emitters (especially 11C). For the immediate future, new projects are planned, e. g. using the proliferation marker 18F-fluoro‑L- hymidine, or neuro‑oncological studies using the proteosynthesis and amino acid transport marker 11C- methionine, and eventually also other compounds applicable outside ofoncology. The existence of the PET centre at the Masaryk Memorial Cancer Institute therefore offers a wide range of possibilities to both patients and physicians in the Brno region and beyond.
